Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMDStudy confirms subretinal prothesis feasible and well-tolerated with no r...
City Of United Kingdom France General Comunidad Autonoma De Cataluna Stanford University United States
Source: businessinsider.com